Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Ana Oaknin, Claire F. Friedman, Lynda D. Roman, Anishka D'Souza, Irene Brana, François-Clement Bidard, Jonathan Goldman, Edwin A. Alvarez, Valentina Boni, Adam C. ElNaggar, Rodolfo Passalacqua, Khanh T.M. Do, Alessandro D. Santin, Kiana Keyvanjah, Feng Xu, Lisa D. Eli, Alshad S. Lalani, Richard P. Bryce, David M. Hyman, Funda Meric-Bernstam, David B. Solit, Bradley J. Monk

Open source

DOI: 10.1016/j.ygyno.2020.07.025
Published: 2020-10
Container: Gynecologic Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2020.07.025,
  title = {Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial},
  author = {Ana Oaknin and Claire F. Friedman and Lynda D. Roman and Anishka D'Souza and Irene Brana and François-Clement Bidard and Jonathan Goldman and Edwin A. Alvarez and Valentina Boni and Adam C. ElNaggar and Rodolfo Passalacqua and Khanh T.M. Do and Alessandro D. Santin and Kiana Keyvanjah and Feng Xu and Lisa D. Eli and Alshad S. Lalani and Richard P. Bryce and David M. Hyman and Funda Meric-Bernstam and David B. Solit and Bradley J. Monk},
  year = {2020},
  journal = {Gynecologic Oncology},
  doi = {10.1016/j.ygyno.2020.07.025},
  url = {https://doi.org/10.1016/j.ygyno.2020.07.025}
}

RIS

TY  - JOUR
TI  - Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
AU  - Ana Oaknin
AU  - Claire F. Friedman
AU  - Lynda D. Roman
AU  - Anishka D'Souza
AU  - Irene Brana
AU  - François-Clement Bidard
AU  - Jonathan Goldman
AU  - Edwin A. Alvarez
AU  - Valentina Boni
AU  - Adam C. ElNaggar
AU  - Rodolfo Passalacqua
AU  - Khanh T.M. Do
AU  - Alessandro D. Santin
AU  - Kiana Keyvanjah
AU  - Feng Xu
AU  - Lisa D. Eli
AU  - Alshad S. Lalani
AU  - Richard P. Bryce
AU  - David M. Hyman
AU  - Funda Meric-Bernstam
AU  - David B. Solit
AU  - Bradley J. Monk
PY  - 2020
JO  - Gynecologic Oncology
DO  - 10.1016/j.ygyno.2020.07.025
UR  - https://doi.org/10.1016/j.ygyno.2020.07.025
ER  -

APA

Oaknin, A., Friedman, C. F., Roman, L. D., D'Souza, A., Brana, I., Bidard, F., Goldman, J., Alvarez, E. A., Boni, V., ElNaggar, A. C., Passalacqua, R., Do, K. T., Santin, A. D., Keyvanjah, K., Xu, F., Eli, L. D., Lalani, A. S., Bryce, R. P., Hyman, D. M., Meric-Bernstam, F., Solit, D. B., & Monk, B. J. (2020). Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2020.07.025

Source records

crossref · retrieved 2026-09-27T10:28:01.475Z